NCT00401856View on ClinicalTrials.gov

CMR to Assess Fibrosis in Cardiomyopathy Using Eplerenone

PHASE4CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

April 2, 2013

Study Completion Date

April 2, 2013

Conditions
Cardiomyopathy
Interventions
DRUG

Eplerenone

50mg oral route

DRUG

Placebo

Placebo is identical to eplerenone but the active ingredient is absent

Trial Locations (1)

SW3 6NP

Royal Brompton & Harefield NHS Trust, London

All Listed Sponsors
lead

Royal Brompton & Harefield NHS Foundation Trust

OTHER

NCT00401856 - CMR to Assess Fibrosis in Cardiomyopathy Using Eplerenone | Biotech Hunter | Biotech Hunter